copy of dr. borghaei on the current landscape of immunotherapy in nsclc
Published 5 years ago • 35 plays • Length 0:18Download video MP4
Download video MP3
Similar videos
-
2:03
dr. borghaei on the current landscape of immunotherapy in nsclc
-
0:24
copy of dr. borghaei on molecular profiling in lung cancer
-
1:11
dr. borghaei on immunotherapy versus chemotherapy and immunotherapy in nsclc
-
1:37
dr. borghaei on anticipated trials evaluating immunotherapy in nsclc
-
9:17
the emerging landscape of immunotherapy in nsclc
-
1:36
dr. borghaei on the search for biomarkers in lung cancer
-
2:02
dr. borghaei on emerging biomarkers in nsclc
-
1:41
dr. borghaei on reporting immunotherapy-related aes in lung cancer
-
1:54
the evolving landscape of immunotherapy in nsclc
-
2:33
immunotherapy for lung cancer: current landscape and challenges
-
2:05
dr. borghaei on the management of immune-related side effects in lung cancer
-
1:33
dr. borghaei on the fda approval of nivolumab in small cell lung cancer
-
1:29
dr. borghaei on the clinical utility of pd-l1 in advanced nsclc
-
0:36
dr. camidge on the fda approval of pembrolizumab for squamous nsclc
-
0:39
dr. lopes on the fda approval of nivolumab/ipilimumab in nsclc
-
1:02
dr. borghaei on immune-related adverse events in lung cancer
-
1:22
dr. bauml on the use of immunotherapy in oligometastatic nsclc
-
2:17
dr. borghaei on the checkmate-227 trial in nsclc
-
1:55
dr. gandara on the impact of immunotherapy on the tumor microenvironment in lung cancer